Company Filing History:
Years Active: 2018
Title: Innovations in Hematology: The Contributions of Feng Li
Introduction
Feng Li is an accomplished inventor based in Marlborough, MA (US), known for his significant contributions to the field of hematology. With a focus on stem cell research, he has developed innovative methods for generating essential blood components.
Latest Patents
Feng Li holds a patent for a groundbreaking invention titled "Large scale generation of functional megakaryocytes and platelets from human embryonic stem cells under stromal-free conditions." This invention provides a method for generating megakaryocytes and platelets, utilizing human embryonic stem cell-derived hemangioblasts for differentiation. The method is designed to operate under serum and stromal-free conditions, directing human embryonic stem cells towards megakaryocytes through embryoid body formation and hemangioblast differentiation. Additionally, the patent outlines a method for treating subjects in need of platelet transfusion.
Career Highlights
Feng Li is associated with Stem Cell & Regenerative Medicine International, Inc., where he continues to advance research in regenerative medicine. His work has the potential to transform treatment options for patients requiring blood component therapies.
Collaborations
Feng Li collaborates with Shi-Jiang Lu, contributing to the advancement of research in their field.
Conclusion
Feng Li's innovative work in generating megakaryocytes and platelets from human embryonic stem cells represents a significant advancement in hematology. His contributions are paving the way for new treatment options in regenerative medicine.